1. China Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Shanghai United Imaging Healthcare Co., Ltd. Class A

Shanghai United Imaging Healthcare Co., Ltd. Class A

SSSE:688271
112.18
CNY
+0.68
(+0.61%)
83.43BMarket Cap
Oct 29Next Earn
Shanghai United Imaging Healthcare Co., Ltd. Class A
SSE:688271
(Shanghai Stock Exchange)

Recent

price

112.18

P/E

ratio

- -

div

yld

0.13%

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
2.81
3.62
8.29
10.03
12.22
13.87
12.57
16.83
- -
Revenue per Share
-0.17
-0.09
1.3
1.96
2.19
2.4
1.54
2.28
- -
Basic EPS, GAAP
-0.48
-0.47
3.75
0.82
-0.08
-1.15
-3.13
0.71
- -
Free Cash Flow per Basic Share
0.09
0.09
0.08
0.01
- -
0.2
0.37
0.21
0.14
Dividend per Share
3.19
3.1
4.97
6.96
21.21
22.89
24.15
26.17
26.73
Book Value per Share
2.49
2.31
4.14
6.03
20.14
21.71
22.5
23.79
23.89
Tangible Book Value per Share
724
824
695
723
756
823
819
820
822
Basic Weighted Avg Shares
2,035
2,979
5,761
7,254
9,238
11,411
10,300
13,800
- -
Sales/Revenue/Turnover
-10.09
1.51
20.83
22.95
21.19
17.44
12.1
15.36
- -
Operating Margin (%)
105
140
192
248
278
346
412
558
- -
Depreciation Expense
-126
-74
903
1,417
1,656
1,974
1,262
1,869
- -
Net Income, GAAP
- -
- -
18.91
17.32
14.05
7.68
8.12
6.93
- -
Effective Tax Rate (%)
-6.18
-2.47
15.67
19.54
17.93
17.3
12.25
13.55
- -
Profit Margin (%)
1,365
603
1,321
2,508
14,133
14,430
13,818
13,593
13,257
Working Capital
390
320
- -
106
102
117
84
253
232
LT Debt
2,461
2,422
3,610
5,034
17,474
18,881
19,906
21,561
22,021
Total Equity
- -
- -
22.19
28.84
14.22
10.66
6.31
8.54
- -
Return on Invested Capital (%)
- -
- -
21.77
30.65
14.63
10.75
6.48
8.75
- -
Return on Capital (%)
- -
-3.23
30.91
32.81
14.71
10.86
6.51
9.01
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1,003
1,384
1,584
LT Borrowings
- -
- -
- -
LT Finance Leases
253
244
232
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
824
824
824
Market Capitalization
103,432
92,306
83,430

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
22,873
22,752
23,518
Cash, Cash Equivalents & STI
10,429
8,920
8,949
Accounts Receivable, Net
5,590
5,725
5,867
Inventories
5,729
6,624
7,238
Total Current Liabilities
9,280
9,229
10,262
Payables & Accruals
- -
- -
- -
ST Debt
1,003
1,384
1,584
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
61.67%
8.31%
Free Cash Flow
- -
274.8%
-122.84%
Net Income, GAAP
- -
21.02%
48.14%
Sales/Revenue/Turnover
- -
20.21%
33.98%
Total Cash Common Dividend
- -
3,422.31%
-42%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,350
2,983
1,621
3,346
10,300
2025
2,478
3,538
- -
4,941
13,800
2026
2,908
4,144
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.44
0.72
-0.34
0.72
1.54
2025
0.45
0.77
- -
0.91
2.28
2026
0.48
0.61
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
0.25
0.12
0.37
2025
- -
- -
- -
0.13
0.21
2026
- -
0.01
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Shanghai United Imaging Healthcare Co., Ltd. (United Imaging) engages in the design, manufacture, and global distribution of advanced medical imaging equipment and related digital solutions, focused on providing integrated imaging workflows across clinical radiology, oncology, neurology, and cardiology. Primary products and services include molecular imaging systems (PET/CT, PET/MR), magnetic resonance imaging (MRI) platforms and accessories, computed tomography (CT) scanners, X-ray imaging systems, and radiation therapy equipment; radiopharmaceuticals and tracers; life science instruments and related consumables; United Imaging Cloud services for image management, analytics, and AI-enabled workflow optimization; after-sales support, maintenance, and training services; and custom turnkey imaging programs and implementation consulting for hospital networks and research institutions. The company also develops software platforms for image reconstruction, interpretation, and data interoperability, including AI-driven diagnostic tools and cloud-based collaboration solutions. Geographic operations span domestic and international markets with manufacturing facilities and regional subsidiaries serving the Americas, Europe, the Middle East, Asia-Pacific, and other regions, enabling sales, installation, service, and local regulatory compliance. Founded in 2011, headquarters are in Shanghai, China, with a global footprint that includes regional offices and demonstration centers to support customer adoption, training, and clinical integration. Subsidiaries and corporate relationships reinforce a diversified product ecosystem and scale across the full imaging lifecycle from equipment sales to cloud-enabled data management and operational optimization. The company’s latest major changes include strategic partnerships and collaborations to expand product deployment and clinical validation, continued enhancement of its uMI imaging portfolio with new imaging capabilities and upgrades, additional regulatory clearances and market entries for expanded regional access, and organizational or regional realignments to support faster global delivery and post-sale services. United Imaging maintains ongoing initiatives in product pipeline advancement, clinical research collaborations, and expanded service networks to address evolving demand in radiology, oncology, neurology, and life sciences.